Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448005 · ClinicalTrials.gov registry record
LifeVest Post-CABG Registry
A clinical trial, sponsored by Zoll Medical Corporation.
- Terminated
- Registry status
- 69
- Enrollment target
NCT01448005 is a clinical trial that was terminated before completion, run by Zoll Medical Corporation. The registered enrollment target is 69 participants.
The verdict
NCT01448005 was terminated before completion, sponsored by Zoll Medical Corporation.
- TERMINATED
- Registry status
- 69 participants
- Enrollment target
Study Summary
This is a multi-center prospective registry of patients with an ejection fraction (EF) ≤ 35% following coronary artery bypass graft (CABG) surgery in order to test the hypothesis that wearable defibrillators (WD) will decrease overall mortality after discharge by decreasing arrhythmic death in this select population with high risk for sudden cardiac death (SCD). This is a pilot project to determine the feasibility of a larger-scale study.
Interventions
- DEVICE wearable defibrillator (LifeVest)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01448005
The ClinicalTrials.gov registry entry for NCT01448005 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which wearable defibrillator (LifeVest) is the first listed.
NCT01448005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01448005 about?
NCT01448005 is a clinical study titled "LifeVest Post-CABG Registry". This is a multi-center prospective registry of patients with an ejection fraction (EF) ≤ 35% following coronary artery bypass graft (CABG) surgery in order to test the hypothesis that wearable defibrillators (WD) will decrease overall mortality after discharge by decreasing arrhythmic death in this ...
What is the current status of trial NCT01448005?
This trial is currently terminated. The enrollment target is 69 participants. The study started on 2011-02. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01448005?
The interventions under investigation include: wearable defibrillator (LifeVest) (DEVICE).
Who is sponsoring clinical trial NCT01448005?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.